mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.06 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.06 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.07 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.07 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.07 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.07 |